AN INTERFERON- AND RIBAVIRIN-FREE 12-WEEK REGIMEN OF ONCE-DAILY VX-135 AND DACLATASVIR IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 HCV INFECTIONE. Gane,C. Stedman,V. Garg,S. George,T. Kieffer, J. Krop,A. Lawal, L. Lan,R. RubinJournal of Hepatology（2014）引用 9|浏览14暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
